Deferred Sanctions Leave Hope For Takeda In Actos MDL

By Sindhu Sundar (February 3, 2014, 6:14 PM EST) -- A Louisiana federal judge's scathing criticism of Takeda Pharmaceuticals America Inc.'s document destruction threatens to cripple Takeda's odds in thousands of cases in multidistrict litigation over its diabetes drug, but attorneys see an opening for escape for the company and others facing similar discovery sanctions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!